Novo Nordisk's pricing tactics from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, stating the stark distinction amongst U.S. costs and people in Europe and copyright. Information: Both equally Rybelsus and copyright a